The lens and cataract in diabetes

International Ophthalmology Clinics

Volumn 38, Issue 2, 1998, Pages 37-67

  Bron, Anthony J ^a   Brown, Nicholas A P ^a   Harding, John J ^a   Ganea, Elena ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DICHLOROBENZYL) 1,2 DIHYDRO 3 METHYL 2 OXO 4 QUINOLINEACETIC ACID; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; AQUAPORIN; AQUAPORIN D; ASCORBIC ACID; DIHYDROXYACETONE; FRUCTOSE; GALACTOSE; GLUCOSAMINE; GLUCOSE; GLUCOSE 1 PHOSPHATE; GLUCOSE 6 PHOSPHATE; GLYCERALDEHYDE; LENS PROTEIN; QUERCETIN; RIBOSE; SORBINIL; UNCLASSIFIED DRUG; XYLOSE;

CATARACT; DIABETIC RETINOPATHY; FLUORESCENCE; GLYCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LENS DISEASE; LIGHT SCATTERING; OSMOTIC STRESS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031843051     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199803820-00005     Document Type: Review

References (284)

1. Forbes J, Brown NAP, Harris MI, et al. Growth of the lens in childhood. Eye 1993;1:1
2. Brown NAP, Tripathi R. Loss of the anterior subcapsular clear zone of the lens. Prognostic significance in cataract formation. Trans Ophthalmol Soc UK 1974;94:29-45
3. Caruelle D, Groux-Muscatelli B, Gaudrie A, et al. Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J Cell Biochem 1989;9:117-128
4. McAvoy JW, Chamberlain CG. Growth factors in the eye. Prog Growth Factor Res 1990;2: 29-43
5. Bassa L, Zelenka PS, Serrano J, De Pablo F. Insulin and IGF receptors are developmentally regulated in the chick embryo eye lens. Exp Cell Res 1987;168:561-566
6. Hollenberg MD. Receptors for insulin and epidermal growth factor. Relation to synthesis of DNA in cultured rabbit lens epithelium. Arch Biochem Biophys 1975;171:371-377
7. Gospodarowicz D, Mescher AL, Brown KD, Birdwell CR. The role of fibroblast growth factor and epidermal growth factor in the proliferative response of the corneal and lens epithelium. Exp Eye Res 1977;25:631-649
8. Sparrow JM, Bron AJ, Brown NAP, et al. The Oxford clinical cataract classification and grading system. Int Ophthalmol 1986;9:207-225
9. Bron AJ, Sparrow J, Brown NAP, et al. The lens in diabetes. Eye 1993;7:260-275
10. Weale RA. The aging eye. London: HK Lewis, 1963.
11. van Heyningen R. The human lens: III. Some observations on the post-mortem lens. Exp Eye Res 1972;13:155-160
12. Delaye M, Tardieu A. Short-range order of crystallin proteins accounts for eye lens transparency. Nature 1983;302:415-417
13. Yorio T, Bentley PJ. The effects of hyperosmotic agents on the electrical properties of the amphibian lens in vitro. Exp Eye Res 1976;22:195-208
14. Lerman S, Borkman RF. Spectroscopic evaluation and classification of the normal aging and cataractous lens. Ophthalmic Res 1976;8:335-353
15. Giles KM, Harris JE. The accumulation of 14C from uniformly labeled glucose by the normal and diabetic rabbit lens. Am J Ophthalmol 1959;48:508
16. Trayhurn P, van Heyningen R. The metabolism of amino acids in the bovine lens: their oxidation as a source of energy. Biochem J 1973;136:67-75
17. Kinoshita JH, Kern HL, Merola LO. Factors affecting the cation transport of calf lens. Biochim Biophys Acta 1961;7:458
18. Kinoshita JH. Cataracts in galactosemia. The Jonas Friedenwald Memorial Lecture. Invest Ophthalmol 1965;4:786-799
19. Gorthy WC, Morrill DJ, Anderson JW. Anterior polar cataract development in mutant wistar rats. An ultrastructural study. In: Aging of the lens. Regnault F, Hockwin D, Courtois Y, eds. Amsterdam: Elsevier, 1980:207-222
20. Iwata S. Calcium-pump and its modulator in the lens: a review. Curr Eye Res 1985;4: 299-304
21. Williams MR, Duncan G, Croghan PC, et al. pH regulation in tissue-cultured bovine lens epithelial cells. J Membr Biol 1992;129:179-187
22. Duncan G. Relative permeabilities of the lens membranes to sodium and potassium. Exp Eye Res 1969;8:315-325
23. Wintour EM. Brief review: Water channels and area transporters. Clin Exp Pharmacol Physiol 1997;24:1-9
24. Shiels A, Bassnett S. Mutations in the founder of the MIP gene family underlie cataract development in the mouse. Nat Genet 1996;12:212-215
25. Rossie BC, Geering K, Kraehenbuhl JP. Regulation of the sodium pump: how and why? Trends Biochem Sci 1987;12:483-487
26. Duncan G, Marcantonio JM, Tomlinson J. Lens calcium and cataract. In: Obrecht C, Stark LW, eds. Presbyopia research. 1991: New York: Plenum Press, 33-39
27. Sippel TO. Changes in the water, protein and glutathione contents of the lens in the course of galactose cataract development in rats. Invest Ophthalmol 1966;5:568-575
28. Yarat A, Uguz Z, Ustunel A, Emekli N. Lens glutathione, lens protein glycation and electrophorectic patterns of lens proteins in STZ induced diabetic rats. Glycoconj J 1995;12:622-626
29. Altomare E, Vendemiale G, Grattagliano I, et al. Human diabetic cataract: role of peroxidation. Diabetes Metab 1995;21:173-179
30. Cheng HM, Chylack LT. Lens metabolism. The ocular lens: structure, function and pathology. In: Maisel H, ed. New York: Marcel Dekker, 1985:223-264
31. Hightower KR, Riley MV, McCready J. Regional distribution of calcium in alloxan diabetic rabbit lens. Curr Eye Res 1989;8:517-522
32. Costagliola C, Iuliano G, Menzione M, et al. Systemic human disease as oxidative risk factors in cataractogenesis: I. Diabetes. Ophthalmic Res 1988;20:308-316
33. Reddy DVN, Klethi J, Kinsey VE. Studies on the crystalline lens: XII. Turnover of glycine and glutamic acid in glutathione and opthalmic acid in the rabbit. Invest Ophthalmol 1966;5:594-600
34. Malone JI, Lowitt S, Cook WR. Nonosmotic diabetic cataracts. Pediatr Res 1990;27:293-296
35. Harding JJ. Cataract: biochemistry, epidemiology and pharmacology. London: Chapman & Hall, 1991
36. Simonelli F, Cotticelli L, Iura A, et al. The decrease of free epsilon-amino groups in senile and diabetic cataracts. Ophthalmic Res 1990;22:160-165
37. Duhaiman AS. Glycation of human lens proteins from diabetic and (nondiabetic) senile cataract patients. Glycoconj J 1995;12:618-621
38. Bensch KG, Fleming JE, Lohman W. The role of ascorbic acid in senile cataract. Proc Natl Acad Sci USA 1985;82:7193-7196
39. Ortwerth BJ, Olesen PR. Ascorbic acid-induced crosslinking of lens proteins: evidence supporting a Maillard reaction. Biochim Biophys Acta 1988;956:10-22
40. Brownlee M, Cerami A. The biochemistry of complications of diabetes mellitus. Annu Rev Biochem 1984;50:385-432
41. Sell D, Nagaraj RH, Grandhee SK, et al. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging and uremia. Diabetes Metab Rev 1991;7: 239-251
42. Vasan S, Zhang X, Zhang X, et al. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 1993;382:275-278
43. Brownlee M, Vlassera H, Kooney A, et al. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986;232:1629-1632
44. Lewis BS, Harding JJ. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins. Exp Eye Res 1990;50:463-467
45. Swamy-Mruthinti S, Green K, Abraham EC. Scheimpflug densitometric analysis of cataracts in diabetic rats: correlation with glycation. Ophthalmic Res 1996;28:230-236
46. Dyer DG, Blackledge JA, Katz BM, et al. The Maillard reaction in vivo. Z Ernahrungswiss 1991;30:29-45
47. Araki N, Ueno N, Chakrabarti B, et al. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 1992;267:10211-10214
48. Nagaraj RH, Sell DR, Prabhakaram M, et al. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA 1991;8:10257-10261
49. Lyons TJ, Silvestri G, Dunn JA, et al. Role of glycation in modification of lens crystallins in diabetic and non-diabetic senile cataracts. Diabetes 1991;40:1010-1015
50. Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 1991;266:11649-11653
51. Baynes JW, Watkins NG, Fisher CI, et al. The Amadori product on protein: structure and reactions. In: Baynes JW, Monnier V, eds. The Maillard reaction in ageing, diabetes and nutrition. New York: Liss, 1989:43-67
52. Beswick HT, Harding JJ. Conformational changes induced in lens and crystallins by modification with glucose 6-phosphate. Implications for cataract. BiochemJ 1987;246: 761-769
53. Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res 1987;44:269-282
54. Blakytny R, Harding JJ. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen. Exp Eye Res 1992;54:509-518
55. Santini SA, Mordente A, Meucci E, et al. Conformational stability of α-crystallin: evidence for a destabilising effect of ascorbate. Biochem J 1992;287:107-112
56. van Heyningen R. The metabolism of D-glyceraldehyde by the lens. Biochem J 1969; 112:211-220
57. Monnier VM, Stevens VJ, Cerami A. Maillard reactions involving proteins and carbohydrates in vivo: relevance to diabetes mellitus and ageing. Prog Food Nutr Sci 1981;5: 315-327
58. Liang JN, Rossi MT. In vitro non-enzymatic glycation and formation of browning products in the bovine lens α-crystallin. Exp Eye Res 1990;50:367-371
59. van Boekel MAM, Hoenders HJ. Glycation-induced crosslinking of calf lens crystallins. Exp Eye Res 1991;53:89-94
60. Swamy MS, Abraham EC. Differential glycation of rat α-, β- and γ-crystallins. Exp Eye Res 1991;52:439-444
61. Hunt JV, Wolff SP. Is glucose the sole source of tissue browning in diabetes mellitus? FEBS Lett 1990;269:258-260
62. Raza K, Harding JJ. Non-enzymic modification of lens proteins by glucose and fructose: effects of ibuprofen. Exp Eye Res 1991;52:205-212
63. Swamy MS, Tsai C, Abraham A, Abraham EC. Glycation mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphates in vitro. Exp Eye Res 1993;56:177-185
64. Stevens VJ, Rouzer CA, Monnier VM, Cerami A. Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA 1978;75:2918-2922
65. Ajiboye R, Harding JJ. The non-enzymic glycosylation of bovine proteins by glucosamine and its inhibitions by aspirin, ibuprofen and glutathione. Exp Eye Res 1989; 49:31-41
66. Huby R, Harding JJ. Non-enzymatic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced gluthathione. Exp Eye Res 1988;47:53-59
67. van Boekel MAM, Hoenders HJ. Glycation-induced crosslinking of calf lens crystallins. Exp Eye Res 1991;53:89-94
68. Kamei A. Glycation and insolubility of human lens proteins. Chem Pharm Bull (Tokyo) 1992;40:2787-2791
69. Prabhakaram M, Ortworth BJ. The glycation and crosslinking of isolated lens crystallins by ascorbic acid. Exp Eye Res 1992;55:451-459
70. Ganed E, Rixon KC, Harding JJ. Binding of glucose, galactose and pyridoxal phosphate to lens crystallins. Biochim Biophys Acta 1994;1226:286-290
71. Pande A, Garner WH, Spector A. Glucosylation of human lens protein and cataractogenesis. Biochem Biophys Res Commun 1979;89:1260-1266
72. Ansari NH, Awasthi YG, Srivastava SK. Role of glycosylation in protein disulphide formation and cataractogenesis. Exp Eye Res 1980;31:9-19
73. Kasai K, Nakamura T, Kase N, et al. Increased glycosylation of proteins from cataractous lenses in diabetes. Diabetologia 1983;25:36-38
74. Garlick RL, Mazer JS, Chylack Jr LT, et al. Nonenzymatic glycation of human lens crystallin. Effect of aging and diabetes mellitus. J Clin Invest 1984;74:742-1749
75. Rao GN, Cotlier E. Free epsilon amino groups and 5-hydroxymethylfurfural contents in clear and cataractous human lenses. Invest Ophthalmol Vis Sci 1986;27:98-102
76. Liang JN, Hershorin LL, Chylack LT. Non-enzymatic glycosylation in human diabetic lens crystallins. Diabetologia 1986;29:225-228
77. Gopalakrishna K, Pattabiraman TN. Effect of in vitro glycosylation on the solubility of lens proteins. Indian J Med Res 1986;83:210-215
78. Oimomi M, Macda Y, Hata F, et al. Glycation of cataractous lens in non-diabetic senile subjects and in diabetic patients. Exp Eye Res 1988;46:415-420
79. Vidal P, Fernandez-Vigo J, Cabezas-Cerrato J. Low glycation level and browning in human cataracts. Acta Ophthalmol 1988;66:220-222
80. Harding JJ, Crabbe MJC. The lens: development, proteins, metabolism and cataract. In: Davson H, ed. The eye, ed 3. London: Academic, 1984:207-492
81. Granstrom D, Swamy M, Abraham E, Takemoto L. Covalent change in the major intrinsic polypeptide (MIP26K) during cataract development in the streptozotocin-induced diabetic rat. Curr Eye Res 1989;8:589-593
82. Prabhakaram M, Katz ML, Ortwerth BJ. Glycation mediated crosslinking between alpha-crystallin and MP26 in intact lens membranes. Mech Ageing Dev 1996;91:57-78
83. Liang LL. Nonenzymatic advanced glycation in the lens membranes. Exp Eye Res 1993;57:45-49
84. Scalbert P, Birlouez-Aragon L. Relationship between lens protein glycation and membrane structure in human cataract. Exp Eye Res 1993;56:335-340
85. Blakytny R, Harding JJ. Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem J 1992;288:303-307
86. Mimura M, Makino H, Kanatsuka A, et al. Reduction of erythrocyte (Na-K)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Horm Metab Res 1994;26:33-38
87. Lin J. Pathophysiology of cataracts: copper ion and peroxidation in diabetics. Jpn J Ophthalmol 1997;41:30-137
88. Adachi T, Ohta H, Hirano K, et al. Non-enzymatic glycation of human extracellular superoxide dismutase. Biochem J 1991;279:263-267
89. Yan H, Harding JJ. Glycation-induced inactivation and loss of antigenecity of catalase and superoxide dismutase. Biochem J 1997;328:599-605
90. Ganea E. Non-enzymatic glycosylation of -galactosidase, alkaline phosphatase and glucose-6-phosphate dehydrogenase. Rev Roum Biochim 1988;25:101-106
91. Ganea E, Harding JJ. Inactivation of glucose-6-phosphate dehydrogenase by glycation. Biochem Soc Trans 1994;22:245S
92. Garner MH, Bahador A, Sachs G. Non-enzymatic glycation of Na,K-ATPase. Effects on ATP hydrolysis and K occlusion. J Biol Chem 1990;265:15058-15066
93. Gordillo E, Ayala A, BautistaJ, Machado A. Implication of lysine residues in the loss of enzymatic activity of rat liver 6-phosphogluconate dehydrogenase found in aging. J Biol Chem 1989;264:17024-17028
94. Jeffery J, Hobbs I, Jornvall H. Glucose-6-phosphate dehydrogenase from Saccharomyces cerevisiae, characterization of a reactive lysine residue labeled with acetylsalicylic acid. Biochemistry 1985;24:666-671
95. Harding JJ. Lens. Harding JJ, ed. Biochemistry of the eye. London: Chapman & Hall; 1997:110-112
96. Blakytny R, Harding JJ. Bovine and humancrystallins as molecular chaperones: prevention of the inactivation of glutathione reductase by fructation. Exp Eye Res 1997;4: 1051-1058
97. Ganea E, Harding JJ. Molecular chaperones protect against glycation-induced inactivation of glucose 6-phosphate dehydrogenase. Eur J Biochem 1995;231:181-185
98. Heath MM, Rixon KC, Harding JJ. Glycation induced inactivation of malate dehydrogenase: protection by aspirin and a lens molecular chaperone, crystallin. Biochim Biophys Acta 1996;1315:176-184
99. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 1992;89:10449-10453
100. Boyle D, Takemoto L. Characterization of the α-γ and α-β complex: evidence for an "in vivo" functional role of α crystallin as a molecular chaperone. Exp Eye Res 1994; 58:9-16
101. Cherian M, Abraham EC. Diabetes affects crystallin chaperone function. Biochem Biophys Res Commun 1995;212:184-189
102. van Heyningen R. The lens metabolism and cataract. In: Davson H, ed. The eye, ed 2. London: Academic Press, 1969;1:381-488
103. van Heyningen R. The sorbitol pathway in the lens. Exp Eye Res 1962;1:396-404
104. Kinoshita JH. A thirty-year journey in the polyol pathway. Exp Eye Res 1990;50:567-573
105. Kinoshita JH, Merola LO, Dikmak E. Osmotic changes in experimental galactose cataract. Exp Eye Res 1962;1:405-410
106. Kinoshita JH, Merola LO, Satoh K. Osmotic changes caused by the accumulation of dulcitol in the lenses of rats fed with galactose. Nature 1962;194:1085-1087
107. van Heyningen R. Formation of polyols by the lens of the rat with 'sugar' cataract. Nature 1950;184:194-195
108. Kador PF, Kinoshita JH. Diabetic and galactosaemic cataracts. Ciba Found Symp 1984; 06:110-131
109. Friedenwald JS, Rytel D. Contribution to the histopathology of cataract. Arch Ophthalmol 1955;53:825-831
110. von Sallmann L, Carvaggio L, Grimes P, Collins EM. Morphological study of alloxan-induced cataract. Arch Ophthalmol 1958;59:55-67
111. Kinoshita JH, Merola LO. Hydration of the lens during the development of galactose cataract. Invest Ophthalmol 1964;3:577-583
112. Datiles M, Fukui H, Kuwabara T, Kinoshita JH. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Invest Ophthalmol VisSci 1982;22:174-179
113. Collins JG, Corder CN. Aldose reductase and sorbitol dehydrogenase distribution in substances of normal and diabetic rat lens. Invest Ophthalmol Vis Sci 1977;16:242-246
114. Jedziniak JA, Chylack Jr LT, Cheng H-M, et al. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. Invest Ophthalmol Vis Sci 1981;20:314-326
115. Akagi Y, Kador PF, Kuwabara T, Kinoshita JH. Aldose reductase in human retinal mural cells. Invest Ophthalmol Vis Sci 1983;24:1516-1519
116. Varma S, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids. Science 1977;195: 205-206
117. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res 1974;19:577-582
118. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by use of transgenic mice expressing the aldose reductase gene in lens. Proc Natl Acad Sci USA 1995;92:2780-2784
119. Wolff SP, Crabbe MJC. Low apparent aldose reductase activity produced by monosaccharide autoxidation. Biochem J 1985;226:625-630
120. Crabbe MJC. Aldose reductase inhibitors and cataract. Int Ophthalmol 1991;15:25-36
121. Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. J Biol Chem 1965;240:877-882
122. Crabbe MJC, Wolff S. Rat lens aldose reductase and polyol production. Biochem J 1987; 247:493-496
123. Crabbe MJC. Discussion on sugar cataracts. Ciba Found Symp 1984;106:123-131
124. Wilson DK, Bohren KM, Gabbay KH, Quiocho FA. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 1992;257:81-84
125. Hara A, Nakayama T, Harada T, et al. Distribution and characterization of dihydrodiol dehydrogenases in mammalian ocular tissues. Biochem J 1991;275:113-119
126. Petrash JM, Tarle I, Wilson DK, Quiocho FA. Aldose reductase catalysis and crystallography. Diabetes 1994;43:955-959
127. Ansari NH, Bhatnagar A, Fulep E, et al. Trolox protects hyperglycaemia-induced cataractogenesis in cultured rat lenses. Res Commun Chem Pathol Pharmacol 1994;84:93-104
128. Trevithick JR, Creighton MO, Ross WM, et al. Modeling cortical cataractogenesis: II. In vitro effects on the lens of agents preventing glucose and sorbitol induced cataracts. Can J Ophthalmol 1990;16:32-38
129. Trevithick JR, Linklater HA, Mitton KP, et al. Modeling cortical cataractogenesis: IX. Activity of vitamin E and esters in preventing cataracts and gamma-crystallin leakage from lenses in diabetic rats. Ann NY Acad Sci 1989;570:358-371
130. Ross WM, Creighton MO, Stewart-De Hann PJ, et al. Modeling cortical cataractogenesis. III. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 1982;17:61-66
131. Charalampous FC, Hegsted DM. Effect of age and diet on development of cataracts in the diabetic rat. Am J Physiol 1950;161:540-544
132. Patterson JW. Effect of high fat, fructose and casein diet on diabetic cataracts. Proc Soc Exp Biol Med 1955b;90:706
133. Hutton JC, Schofield PJ, Williams JF, et al. The effect of unsaturated-fat diet on cataract formation in diabetic rats. Br J Nutr 1976;36:161
134. Linklater HA, Dzialozynski T, McLeod HL, et al. Modelling cortical cataractogenesis: XI. Vitamin C reduces gamma-crystallin leakage from lenses in diabetic rats. Exp Eye Res 1990;51:241-247
135. Chand D, El-Agnizy HK, Richards RD, Varma SD. Sugar cataracts in vitro: implications of oxidative stress and aldose reductase I. Exp Eye Res 1982;35:491-497
136. Kador PF. Overview of the current attempts towards the medical treatment of cataract. Ophthalmology 1983;90:352-364
137. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinoistides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1967;316: 599-606
138. Nagata M, Hohman TC, Nishimura C, et al. Polyol and vacuole formation in cultured canine lens epithelial cells. Exp Eye Res 1989;48:667-677
139. Datiles M, Kador PF, Fukui H, et al. Corneal reepithelialization in galactosemic rats. Invest Ophthalmol Vis Sci 1983;24:563-569
140. Fukushi S, Merola LO, Tanaka M, et al. Re-epithelialization of denuded corneas in diabetic rats. Exp Eye Res 1980;31:611-621
141. Kinoshita JH, Dvornik D, Draml M, Gabbay KH. The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens. Biochim Biophys Acta 1968;158:472-475
142. Fukushi S, Merola LO, Kinoshita JH. Altering the course of cataracts in diabetic rats. Invest Ophthalmol Vis Sci 1980a;9:313-315
143. Hu TS, Datiles M, KinoshitaJH. Reversal of galactose cataract with sorbinil in rats. Invest Ophthalmol Vis Sci 1983;24:640-644
144. Varma SD. Aldose reductase and the etiology of diabetic cataracts. Curr Top Eye Res 1980;3:91
145. Bonting SJ. Na-K activated adenosinetriphosphatase and active cation transport in the lens. Invest Ophthalmol 1965;4:723-738
146. Duncan G, Hightower KR, Gandolfi SA, et al. Human lens membrane cation permeability increases with age. Invest Ophthalmol Vis Sci 1989;30:1855-1859
147. Weale RA. Physical changes due to age and cataract. In: Duncan G, ed. Mechanisms of cataract formation in the human lens. London: Academic, 1981
148. Weale RA. A Biography of the eye: development, growth, age. London: HK Lewis, 1982
149. Takemoto L, Takehana M, Horwitz J. Covalent changes in MIP 26K during aging of the human lens membrane. Invest Ophthalmol Vis Sci 1986;27:443-446
150. Garner MH, Spector A. ATP hydrolysis kinetics by Na, K-ATPase in cataract. Exp Eye Res 1986;42:339-348
151. Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res 1981;33: 673-681
152. Simonelli F, Nesti A, Pensa M, et al. Lipid peroxidation and human cataractogenesis in diabetes and severe myopia. Exp Eye Res 1989;49:181-187
153. Garcia-Castineiras S, Velazquez S, Martinez P, Torres N. Aqueous humor hydrogen peroxide analysis with dichlorophenol-indophenol. Exp Eye Res 1992;55:9-19
154. Huggert A. The appearance of the band of disjunction of the lens in diabetes mellitus. Am J Ophthalmol 1953;31:227-234
155. Brown NP, Hungerford J. The influence of the size of the lens in ocular disease. Trans Ophthalmol Soc UK 1982;102:359-363
156. Sparrow JM, Bron AJ, Brown NAP, Neil HAW. Biometry of the crystalline lens in early-onset diabetes. Br J Ophthalmol 1990;74:654-660
157. Sparrow JM, Bron AJ, Brown NAP, Neil HAW. Biometry of the crystalline lens in late-onset diabetes: the importance of diabetes type. Br J Ophthalmol 1992;76:428-433
158. Brown NAP, Bron AJ. Lens disorders: a clinical manual of cataract diagnosis. London: Butterworth-Heinemann. 1996
159. Laurent M, Kern P, Regnault F. Thickness and collagen metabolism of lens capsule from genetically prediabetic mice. Ophthalmic 1981;13:93
160. Lutze M, Bresnick GH. Lenses of diabetic patients "yellow" at an accelerated rate similar to older normals. Invest Ophthalmol Vis Sci 1991;2:194-199
161. Weiss JN, Nishio I, Clark JI, et al. Early detection of cataractogenesis by laser light scattering. Invest Ophthalmol Vis Sci (ARVO suppl) 1982;41
162. Bursell SE, Baker RS, WeissJN, et al. Clinical photon correlation spectroscopy evaluation of human diabetic lenses. Exp Eye Res 1989;49:241-258
163. Bursell SE, Karalekas DP, Craig MS. The effect of acute changes in blood glucose on lenses in diabetic and non-diabetic subjects using quasi-elastic light scattering spectroscopy. Curr Eye Res 1989;8:821-834
164. Helve J, Nieminen H. Autofluorescence of the human diabetic lens in vivo. Am J Ophthalmol 1976;81:491-494
165. Lerman S. Radiant energy and the eye. (Functional ophthalmology series). New York: MacMillan, 1980
166. Bleeker JC, Van Best JA, Vrij L, et al. Autofluorescence of the lens in diabetic and healthy subjects by fluorophotometry. Invest Ophthalmol Vis Sci 1986;27:791-794
167. Larsen M, Kjer B, Bendtson I, et al. Lens fluorescence in relation to metabolic control of insulin-dependent diabetes mellitus. Arch Ophthalmol 1989;107:59-62
168. Van Wirdum E, Van Best J, Bruining GJ, et al. Blood-retinal and blood-aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters. Graefes Arch Klin Exp Ophthalmol 1989;227:26-29
169. Sparrow JM, Bron AJ, Brown NAP, Neil HAW. Autofluorescence of the crystalline lens in early and late onset diabetes. Br J Ophthalmol 1992;76:25-31
170. Zeimer RC, Noth RM. A new method of measuring in vivo the lens transmittance, and study of lens scatter, fluorescence and transmittance. Ophthalmic Res 1984;16:246-255
171. Sparrow JM. The lens in diabetes Ph.D. thesis, Oxford University, 1988
172. Mantyjarvi M. Myopia and diabetes. A review. Acta Ophthalmol Supp 1988;185:82-85
173. Huggert A. The appearance of the crystalline lens during different stages of transitory changes of refraction. Acta Ophthalmol 1954;32:375-389
174. Fledelius HC. Is myopia getting more frequent. A cross-sectional study of 1416 Danes aged 16 years. Acta Ophthalmol 1983;61:545-559
175. Duke-Elder S. Changes in refraction in diabetes mellitus. Br J Ophthalmol 1925;9:167-187
176. Bellows JG. The crystalline lens in diabetes mellitus. Arch Ophthalmol 1944;32:498-507
177. Fledelius HC. Refractive change in diabetes mellitus around onset or when poorly controlled. Acta Ophthalmol 1987;65:53-57
178. Marmor MF. Transient accomodative paralysis and hyperopia in diabetes. Arch Ophthalmol 1973;89:419-421
179. Birnbaum F, Leu P. Akute Myopisierung und intraokularer Drucksteigerung bei Entgleisung einen juvenilen Diabetes mellitus. Kin Monatsbl Augenheilk 1975;167:613-615
180. Gwinup G, Villarreal A. Relationship of serum glucose concentration to changes in refraction. Diabetes 1976;25:29-31
181. Rosen M. Diabetes mellitus with relative hyperopia. 1956;41:680-681
182. Planten JT. Physiologic optic approach of lens and cataract. Ophthalmologica 1975;171: 249-253
183. Eva PR, Pascoe PT, Vaughan DG. Refractive change in hyperglycaemia: hyperopia, not myopia. Br J Ophthalmol 1982;66:500-505
184. Rosen M. Diabetes mellitus with relative hyperopia. Am J Ophthalmol 1956;41:680-681
185. Planten JT. Changes of refraction in the adult due to changing refractive indices of the layers of the lens. Ophthalmologira 1981;183:86-90
186. Planten JT, Kooijman AC, De Vries B, Woldringh J. Pathological-optic approach of cataract and lens. Ophthalmologica 1978;176:331-334
187. Fagerholm PP, Phillipson BT, Lindstrom B. Normal human lens - the distribution of protein. Exp Eye Res 1981;33:615-620
188. Bours J, Fodisch HJ. Human fetal lens: wet and dry weight with increasing gestational age. Ophthalmic Res 1986;18:363-368
189. Bours J. A re-evaluation of lens wet weight, water content and water-soluble and insoluble crystallins of the ageing human lens, compared with other species. In: Courtois, Fauchaux, eds. Modern trends in aging research, vol 1. 1987:373-379
190. Bours J, Fodisch HJ, and Hockwin O. Age-related changes in water and crystallin content of the fetal and adult human lens, demonstrated by a microsectioning technique. Ophthalmic Res 1987;19:235-239
191. Huizinga A, Bot ACC, De Mul FFM, et al. Local variation in absolute water content of human and rabbit eye lenses measured by Raman microspectroscopy. Exp Eye Res 1989;48:487-496
192. Pierscionek BK, Chan DYC. Refractive index gradient of human lenses. Optom Vis Sci 1989;66:822-829
193. Pierscionek BK. Presbyopia - the effect of refractive index. Clin Exp Optom 1990;73: 23-30
194. Siebinga I, Vrensen GFJM, De Mul FFM, Greve J. Age-related changes in local water and protein content of human eye lenses measured by Raman microspectroscopy. Exp Eye Res 1991;53:233-239
195. Granstrom KO. Refraktionsveranderungen bei diabetes mellitus. Acta Ophthalmol 1933;11:1-161
196. Reddy VN, Schwass D, Chakrapani B, Lim CP. Biochemical changes associated with the development and reversal of galactose cataracts. Exp Eye Res 1976;23:483-493
197. Neilson NV, Vinding T. The prevalence of cataracts in insulin dependent and non-insulin-dependent diabetes mellitus. An epidemiological study of diabetics treated with insulin and oral hypoglcaemic agents OHA. Acta Ophthalmol 1984;62:595-602
198. Caird FI, Pirie A, Ramsell TG. Diabetes and the eye. Oxford: Blackwell, 1969
199. Alt A. A case of transitory lenticular opacity in both eyes in a diabetic patient. Am J Ophthalmol 1906;23:294-298
200. Jackson RC. Temporary cataracts in diabetes mellitus. Br J Ophthalmol 1955;39:629-631
201. Brown CA, Burman D. Transient cataract in a diabetic child with hyperosmolar coma. Br J Ophthalmol 1973;57:429-433
202. Gelvin JB, Thonn VA. The formation and reversal of acute cataracts in diabetes mellitus. J Am Optom Assoc 1993;64:471-474
203. Cornwell M, Lepre F. Acute irreversible cataracts in diabetes mellitus. Aust NZJ Ophthalmol 1995;23:221-222
204. Santiago AP, Rosenbaum AL, Masket S. Insulin-dependent diabetes mellitus appearing as bilateral mature diabetic cataracts in a child. Arch Ophthalmol 1997;15:422-423
205. Cotlier E, Kwan B, Beatty C. The lens as an osmometer. Biochim Biophys Acta 968;150:705
206. Mitchell HS, Dodge WM. Cataracts in rats fed on light lactose rations. J Nutr 935;9:37-49
207. Patterson JW. Development of diabetic cataracts. Am J Ophthalmol 1952;35:68-71
208. Patterson JW. Cataracts caused by carbohydrates. Am J Ophthalmol 1953;36:143-147
209. Patterson JW. Cataractogenic sugars. Arch Biochem Biophys 1955;58:24-30
210. van Heyningen R. The lens: metabolism and cataract In: Davson H, ed. The eye, ed 2. London: Academic, 1969:381-488
211. Jacob TJC, Duncan G. Glucose-induced membrane permeability changes in the lens. Exp Eye Res 1982;34:445-453
212. Corrall RJM. Coincidental changes in conscious level and lens translucency during treatment of diabetic ketoacidosis. Br J Ophthalmol 1957;59:233-235
213. Vinding T, Neilson NV. Two cases of acutely developed cataract in diabetes mellitus. Acta Ophthalmol 1984;62:373-377
214. Chylack LT Jr, Henriques H, Tung W. Inhibition of sorbitol production in human lenses by an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 1978;7:300
215. Pirie A. The biochemistry of the eye. Bibl Ophthalmol 1957;49:287
216. Green H, Solomon SA. Hexokinase of rabbit lens. Arch Ophthalmol 1959;61:616-621
217. Pirie A, van Heyningen R. The effect of diabetes on the content of sorbitol, glucose, fructose and inositol in the human lens. Exp Eye Res 1964;3:124-131
218. Varma S, Schocket SS, Richards RD. Implications of aldose retuctase in cataracts in human diabetes. Invest Ophthalmol Vis Sci 1979;18:237-241
219. Belpoliti M, Maraini G. Sugar alcohols in the lens epithelium of age-related cataract. Exp Eye Res 1993;56:3-6
220. Vadot E, Guibal JP. Pathogenie de la cataracte diabetique. Bull Soc Ophtalmol Fr 1982; 82:1513-1514
221. Lerman S, Moran M. Sorbitol generation and its inhibition by Sorbinil in the aging normal human and rabbit lens and human diabetic cataracts. Ophthalmic Res 1988;20: 348-352
222. Lin LR, Reddy VN, Giblin FJ, et al. Polyol accumulation in cultured human lens epithelial cells. Exp Eye Res 1991;52:93-100
223. Harding JJ, Egerton M, van Heyningen R, Harding RS. Diabetes, glaucoma, sex and cataract: analysis of combined data from two case-control studies. Br J Ophthalmol 1993;77:2-6
224. Klein BEK, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985;92:1191-1196
225. Klein BEK, Klein R. Ocular problems in older Americans with diabetes. Clin Geriatr Med 1990;6:827-837
226. Grey RHB, Malcolm N, O'Reilly D, Morris A. Ophthalmic survey of a diabetic clinic. I. Ocular findings. Br J Ophthalmol 1986;70:797-803
227. Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology 1993;100:1125-1132
228. Knuiman MW, Welborn TA, McCann VJ, et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-1339
229. Howard-Williams J, Hillson RM, Bron A, et al. Retinopathy is associated with higher glycaemia in maturity-onset type diabetes. Diabetologia 1984;27:198-202
230. Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in IDDM. Diabetes 1989;38:460-464
231. Chase HP, Jackson WE, Hoops SL, et al. Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 1989;261:1155-1160
232. Klein R, Moss SE, Klein BE, DeMets DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 1989;149:266-272
233. Moss SE, Klein R, Klein BEK. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101:1061-1070
234. Bernth-Petersen P, Bach E. Epidemiologic aspects of cataract surgery: III. Frequencies of diabetes and glaucoma in a cataract population. Acta Ophthalmol 1983;61(3):406-416
235. Ederer F, Hiller R, and Taylor HR. Senile lens changes and diabetes in two population studies. Am J Ophthalmol 1981;91:381-395
236. Hiller R, Sperduto RJD, Ederer F. Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey. Am J Epidemiol 1983;118:239-248
237. van Heyningen R, Harding JJ. Risk factors for cataract: diabetes, myopia and sex. In: Courtois Y, Forette D, Knook D, eds. Modern trends in aging research, vol 147. 1986; 381-385
238. Harding JJ, Beswick HT, Ajiboye R, et al. Non-enzymic post-translational modification of proteins in aging. A review. Mech Ageing Dev 1989;50:7-16
239. Harding JJ, Egerton M, van Heyningen R, Harding RS. Diabetes, glaucoma, sex and cataract: analysis of combined data from two case control studies. Br J Ophthalmol 1993; 77:2-6
240. Chen TT, Hockwin O, Dobbs R, et al. Cataract and health status: a case control study. Ophthalmic Res 1988;20:1-9
241. Szmyd L, Schwartz B. Association of systemic hypertension and diabetes mellitus with cataract extraction. Ophthalmology 1989;96:1248-1252
242. Caird FI, Hutchinson M, Pirie A. Cataract and diabetes. Br Med J 1964;2:665-668
243. Bartholomew RS, Clayton RM, Cuthbert J, et al. Analysis of individual cataract patients and their lenses: preliminary observations on a population basis. In: Regnault F, Hockwin O, Courtois Y, eds. Ageing of the lens. Amsterdam:Elsevier, 1980;241-261
244. Vassileva P, Jarkov I, Parvova T. On the epidemiology of cataract in Bulgaria. Dev Ophthalmol 1987;15:37-41
245. Harding JJ, Harding RS, Egerton M. Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea. Acta Ophthalmol 1989;67: 510-517
246. Perkins ES. Cataract: refractive error, diabetes and morphology. Br J Ophthalmol 1984;68:293-297
247. Benson WH, Farber ME, Caplan RJ. Increased mortality rates after cataract surgery. Ophthalmology 1988;95:1288-1292
248. van Heyningen R, Harding JJ. Do aspirin-like analgesics protect against cataract? Lancet 1986;1:1111-1113
249. Harding JJ, Egerton M, Harding RS. Protein against cataract by aspirin, paracetamol and ibuprofen. Acta Ophthalmol 1989;67:518-524
250. Harding JJ, Harding RS, Egerton M. Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea. Acta Ophthalmol 1989;67: 510-517
251. Leske MC, Chylack LTJr, Wu SY. The lens opacities case-control study. Risk factors for cataract. Arch Ophthalmol 1991;109:244-251
252. Harding JJ, Rixon KC. Carbamylation of lens proteins: a possible factor in cataractogenesis in some tropical countries. Exp Eye Res 1980;31:567-571
253. Minassian DC, Mehra V, Verrey J-D. Dehydrational crises: a major risk factor in blinding cataract. Br J Ophthalmol 1989;73:100-105
254. Klein R, Klein BEK, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91: 1-9
255. Klein BEK, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995;19:295-300
256. Kreines K, Rowe KW. Cataract and adults diabetes. Ohio Med J 1979;75:782-786
257. Caird FI, Hutchinson M, Pirie A. (1964). Cataract and diabetes. Br Med J 1964;2:665-668
258. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XV. The long-term incidence of macular edema. Ophthalmology 1995;2:7-16
259. Tavani A, Negri E, La Vecchia C. Selected diseases and risk of cataract in women. A case-control study from Northern Italy. Ann Epidemiol 1995;5:234-238
260. Clayton RM, CuthbertJ, Phillips CI, et al. Analysis of individual cataract patients and their lenses: a progress report. Exp Eye Res 1980;31:553-566
261. Dugmore WN, Tun K. Glucose tolerance tests in 200 patients with senile cataract. Br J Ophthalmol 1980;64:689-692
262. Al Samarrai AR, Noor Sunba MS, Ul Hassan M. The incidence of unknown diabetes mellitus and impaired glucose tolerance in idiopathic presenile cataract. Dev Ophthalmol 1989;17:79-81
263. Klein BE, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol 1997;123:338-346
264. Perkins ES. Cataract: refractive error, diabetes and morphology. Br J Ophthalmol 1984; 68:293-297
265. Liang I, Chakrabarti B. Sugar-induced change in near ultraviolet circular dichroism of alpha-crystallin. Biochem Biophys Res Commun 1981;102:180
266. Gabric N, Henc-Petrinovic L, Dekaris I, et al. Timing of cataract surgery in diabetics. Acta Med Croatica 1996;50:25-28
267. Antcliff RJ, Poulson A, Flanagan DW. Phacoemulsification in diabetics. Eye 1996; 10:737-741
268. Chitkara DK, Smerdon DL. Risk factors, complications, and results in extracapsular cataract extraction. J Cataract Refract Surg 1997;23:570-574
269. Kuchle M, Schonherr U, Dieckmann U. Risk factors for capsular rupture and vitreous loss in extracapsular cataract extraction. The Erlangen Ophthalmology Group. Fortschr Ophthalmol 1989;86:417-421
270. Flanagan DW. Current management of established diabetic eye disease. Eye 1993;7: 302-308
271. Sadiq SA, Chatterjee A, Vernon SA. Progression of diabetic retinopathy and rubeotic glaucoma following cataract surgery. Eye 1995;9:728-738
272. Tsopelas N, Kokolakis N, Droutsas D, Theodossiadis G. Extracapsular cataract extraction in diabetic eyes. The role of YAG laser capsulotomy. Doc Ophthalmol 1995;91:17-24
273. Tassignon MJ, De-Groot V, Smets RM, et al. Secondary closure of posterior continuous curvilinear capsulorhexis. J Cataract Refract Surg 1996;22:1200-1205
274. Jones NP, McLeod D, Boulton ME. Massive proliferation of lens epithelial remnants after Nd-YAG laser capsulotomy. 1995;79:261-263
275. Ulbig MR, Hykin PG, Foss AJ, et al. Anterior hyaloidal fibrovascular proliferation after extracapsulare cataract extraction in diabetic eyes. Am J Ophthalmol 1993;115(3):321-326
276. McDermott ML, Puklin JE, Abrams GW, Elitt D. Phacoemulsification for cataract following pars plana vitrectomy. Ophthalmic Surg Lasers 1997;28:558-564
277. Lumme P, Laatikainen LT. Risk factors for intraoperative and early postoperative complications in extracapsular cataract surgery. Eur J Ophthalmol 1994;4:151-158
278. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996;80:789-793
279. Dowler JG, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye 1995;9:313-317
280. Wagner T, Knaflic D, Rauber M, Mester LI. Influence of cataract surgery on the diabetic eye: a prospective study. Ger J Ophthalmol 1996;5:79-83
281. Hirsch RP, Schwartz B. Increased mortality among elderly patients undergoing cataract extraction. Arch Ophthalmol 1983;101:1034-1037
282. Podgor MJ, Cassel GH, Kannel WB. Lens changes and survival in a population-based study. N Engl J Med 1985;313:1438-1444
283. Cohen DL, Neil HAW, Sparrow J, et al. Lens opacity and mortality in diabetes. Diabetic Med 1990;7:615-617
284. Podgor MJ, Kannel WB, Cassel GH, Sperduto RD. Lens changes and the incidence of cardiovascular events among persons with diabetes. Am Heart J 1989;17:642-648